ixazomib citrate 1201902 80 8

Ixazomib Citrate (1201902-80-8) Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and anticancer activity. Product Name: Ixazomib Citrate CAS No.: 1201902-80-8 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C20H23BCl2N2O9 Molecular Weight: 517